MedTrace Logo

CPAP Observance During the COVID-19 (SARS-CoV-2) Pandemic

NCT04775966 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 8477

Last updated 2022-03-22

No results posted yet for this study

Summary

The hypothesis of this work is that the COVID 19 pandemic and the associated lockdowns are likely to modify the adherence to positive airway pressure (PAP) treatments among patients with sleep apnea. Identifying these patients and identifying adherence "trajectories" over time would help mobilize human and telemedicine resources on the patients most in need.

Conditions

  • Sleep Apnea Syndromes

Sponsors & Collaborators

  • University Hospital, Montpellier

    lead OTHER

Principal Investigators

  • Dany Jaffuel, MD,PhD · Montpellier University Hospitals

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-01-15
Primary Completion
2021-02-15
Completion
2021-02-15

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04775966 on ClinicalTrials.gov